Overview
Description
Krka d.d. is a leading generic pharmaceutical company headquartered in Novo mesto, Slovenia, with a global presence spanning over 70 markets. Specializing in the development, production, marketing, and sales of prescription pharmaceuticals, non-prescription health products, and animal health products, Krka d.d. serves healthcare providers and patients worldwide. The company's diverse portfolio addresses multiple therapeutic areas, including cardiovascular, gastrointestinal, central nervous system, pain management, diabetes, and respiratory conditions. Krka's offerings are recognized for their high quality and trusted by more than 100 million users, supported by a workforce exceeding 12,500 employees dedicated to innovation and product excellence. In addition to pharmaceuticals, Krka is also active in health resort and tourist services, reflecting its broader commitment to health and well-being. With a track record of steady financial growth and a strong return on invested capital, the company plays a significant role in the global healthcare sector, particularly in the generic drug manufacturing space.
About
Instrument type
Common stock
Sector
Industry
Country
Poland
MIC code
XWAR